Physician profile
Stuart A Engel
NPI 1750348645
$677.25
in general payments reported to CMS, 2019-2025
10 companies · $96.57 in 2025
The $96.57 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.34 · 2020: $64.19 · 2021: $197 · 2022: $129 · 2023: $14.77 · 2024: $120 · 2025: $96.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $230.19 | 2020-2025 | Collagenase Santyl |
| Kerecis Limited | $149.64 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Tactile Systems Technology INC | $138.21 | 2019-2022 | |
| Medline Industries LP | $59.90 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $19.98 | 2021 | |
| Mimedx Group, INC. | $16.77 | 2025 | |
| Avita Medical Americas, LLC | $16.36 | 2024 | |
| Convatec INC. | $15.76 | 2021 | |
| Lifenet Health | $15.67 | 2025 | Theragenesis Wound Matrix |
| Integra Lifesciences Corporation | $14.77 | 2023 | Tcc-Ez |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Engel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.